Patrick Kilbride is vice president of international intellectual property for the Global Innovation Policy Center (GIPC) at the U.S. Chamber of Commerce. Over the last several years, there has been a growing chorus of voices internationally that have begun to question the role of IP in drug development. In this podcast, we separate fact from fiction around the role of IP in developing new biotech products, the changing global landscape for innovation, and what we need to do to ensure that we don’t throw the IP baby out with the rhetorical bath water.See omnystudio.com/listener for privacy information.